NanoString is highly interested in collaborating with leading academic / research institutions and life science and biopharmaceutical partners to build a differentiated and sustainable platform and high information content applications, based on state-of-the-art genomic, proteomic and multi-omic technologies (at the RNA, protein and DNA levels). Reporting to the Senior VP of Corporate and Business Development and as a key member of the Corporate and Business Development team, the Director/Senior Director, Innovation Licensing & Alliances will be the primary business development lead to identify, evaluate, pursue, transact and implement cutting-edge innovation & technology to enable our Corporate and R&D Roadmaps. This position will be at the forefront of enabling key collaborations and accessing critical technology; and will work hand-in-hand with R&D, Commercial and other cross-functional teams including Legal, Finance and Operations to drive these initiatives forward.
Drive business development / transactional processes to access best-in-class innovation & alliances related to 1) new technologies to enhance and expand the nCounter® Analysis System platform, 2) new applications and content to provide high value, multi-dimensional genetic and proteomic information 3) investigator-driven research to generate new data and publications and 4) novel alliances with academia, governmental agencies, foundations and industrial partners. Specific activities include:
•Discover and prioritize potential opportunities by actively prospecting, collaborating with cross-functional partners and leveraging your network.
•Conduct robust analysis and due diligence to uncover the highest potential opportunities and de-risk decision making.
•Lead deal transaction / negotiation processes that meet strategic, technical and financial goals.
•Partner with R&D, Commercial and other cross-functional teams to accelerate deal making process and implementation.
•Gain internal and external support for the transaction.
•Support the integration and implementation of the technology or collaboration into NanoString.
•As part of a core team, ensure that the R&D roadmap and corporate strategy reflect current thinking and insight to build upon NanoString’s competitive advantage.
•Offer in-depth, multi-faceted knowledge and insight spanning the technology competitive landscape (including genomic and proteomic detection technologies), cancer biology (solid tumors, hematology and/or immune-oncology) and diagnostic/drug development.
•Identify, develop and maintain “peer-to-peer” scientific and business relationships with academia, governmental agencies, foundations, industrial partners and other stakeholders.
•Key member of the Corporate & Business Development team to ensure individual and departmental goals are achieved by providing leadership, company advocacy, team support and driving other key initiatives.